Brief: Athersys Granted Clinical Type B Meeting With FDA For Masters-2 Clinical Trial Protocol Discussion
14/02/2023 13:43
Feb 14 (Reuters) - Athersys Inc ATHX.O :
* ATHERSYS GRANTED CLINICAL TYPE B MEETING WITH FDA FOR
MASTERS-2
CLINICAL TRIAL PROTOCOL DISCUSSION
Source text for Eikon: ID:nBw4WzLDHa
Further company coverage: ATHX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Athersys
See all newsBrief: Athersys Anticipates Terminating Remaining Employees, Effective December 31
Brief: Athersys Extends Near Term Liquidity With Proceeds From Warrant Inducement
U.S. STOCKS ON THE MOVE-Hyatt Hotels, Walmart, Maxeon
U.S. STOCKS ON THE MOVE-Olema Pharma, Akamai Technologies, US banks
Athersys hits record low on flagging bankruptcy risk